Top Markets
#1 Seeker Seeker +134.41%
#2 AI XOVIA AI XOVIA +101.43%
#3 Helium Helium +70.37%
#4 MowCat MowCat +69.17%
#5 Pons Pons +40.95%
#6 UnifAI Network UnifAI Network +35.00%
#7 Zora Zora +29.90%
#8 Bounce Bounce +20.89%
#9 Zylo Ecosystem Zylo Ecosystem +20.85%
#10 TENDIES TENDIES +18.90%
Coin of the day
Seeker Seeker
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Classifica tra le azioni #11763
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Prezzo delle azioni
$17.81
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$661.63M
Variazione (1 giorno)
0.30%
Variazione (1 anno)
23.70%
Paese
US
Scambia Crescent Biopharma, Inc. (CBIO)

Categoria

Healthcare
Rapporto P/S per Crescent Biopharma, Inc. (CBIO)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Crescent Biopharma, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Crescent Biopharma, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH